| Business Summary | | Advanced
Plant
Pharmaceuticals
Inc.
focuses
on
the
research
and
development
of
plant
based
dietary
supplements.
During
July
1999,
the
Company
acquired
exclusive
rights
and
interests
to
a
13-step
process,
which
utilizes
virtually
the
whole
of
the
nutrients
found
in
plants
to
manufacture
all
natural
herbal
dietary
supplements.
The
Company
intends
to
use
this
process
to
manufacture
products
that
it
hopes
to
distribute
worldwide
through
various
sales
distribution
contracts.
The
Company
also
owns
Sinusol,
a
generalized
base
solution
for
the
development
of
an
extensive
line
of
specialty
products
related
to
allergy
and
sinus
conditions.
The
ingredients
include
a
mixture
of
gently
pH-balanced
essential
mineral
oils
that
combat
the
various
symptoms
related
to
allergies
and
sinus
disorders,
including
congestions,
irritated
nasal
mucosa
and
bacterial
and
fungal
infections. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Advanced
Plant
Pharmaceuticals,
Inc.
is
a
development
stage
company
that
utilizes
whole
plants
to
develop
all
natural
dietary
supplements
through
a
thirteen
step
process.
For
the
three
months
ended
3/01,
revenues
totalled
$6
thousand,
up
from
$2
thousand.
Net
loss
decreased
83%
to
$174
thousand.
Revenues
reflect
an
increase
in
sales
from
dietary
supplements.
Lower
loss
reflects
improved
margins
and
lower
S/G/A
costs. | More
from
Market Guide: Significant
Developments |
| Officers | | | FY1999 Pay | |
| Leonard Bielory, M.D., 45 Chairman
and Scientific Director | -- | David Lieberman, 37 Pres,
Director | $135K | Barry Clare, 41 COO | -- | Dollar
amounts are as of 31-Dec-1999 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|